Yunhai Biotech has been selected for the first batch of "Top Solver" projects at the National Precision Medicine Industry Innovation Center
On November 28, 2024, the Precision Medicine Industry Innova...
On November 28, 2024, the Precision Medicine Industry Innova...
On November 18, 2024, the "Sci-Tech Tianfu – Intelligence Co...
On November 8, 2024, Tetrahedral Framework Nucleic Acid Blue...
In 2024, the Nobel Prize in Physiology or Medicine was award...
In a remarkable coincidence, the 2024 Nobel Prize in Physics...
Recently, Professor Yunfeng Lin’s team published a breakthro...
On September 5-6, the 6th Health and Wellness Innovation and...
Professor Toshio Shimokawa, Director of the Data Center at W...
Professor Yunfeng Lin, the Chief Scientist of Yunhai Biotech...
From July 13 to 16, the Chengdu Science and Technology Burea...
In 2024, the inaugural Tetrahedral Framework Nucleic Acid In...
The tetrahedral framework nucleic acid is a nucleic acid mol...
July7, 2024The inaugural Tetrahedral Framework Nucleic Acid ...
On the afternoon of July 6, 2024, the first Academic Committ...
On May 20, 2024, Yunhai Biotechnology and SichuanUniversity ...
On May 14, 2024, Chengdu Yunhai Tetrahedral BiotechnologyCo....
The field oflife sciences is evolving rapidly, with tetrahed...
On April 28,2024, Yunhai Biotechnology, the Chengdu Jinniu D...
On March 5,2024, Chengdu Yunhai Tetrahedral Biotechnology Co...